CRA provided testimony on behalf of plaintiff in litigation regarding a health plan’s use of MFN clauses with hospitals. CRA identified several mechanisms by which the MFN clauses were likely to reduce competition in this matter and demonstrated that they had historically harmed competitors. CRA also analyzed whether this harm to competition was offset by the procompetitive effects of MFN clauses.
Great Thinkers in Marketing series features two chapters from CRA Competition expert
Two academic articles co-authored by CRA’s Dr. Tolga Bilgicer (as the lead author) have been published as two separate chapters in The Research Contributions...